menu
    • menu

    Company profile for Comanche Biopharma

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Comanche is a biopharmaceutical company developing a novel siRNA therapy for the treatment of preeclampsia. Our purpose is to lower the risks of pregnancy and prematurity worldwide by safely sustaining natural pregnancy. We envision a world where all pregnant women have access to safe and effective therapies that are evidence-based, cost-effective and sustainable

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Comanche BiopharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Concord, Massachusetts
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://comanchebiopharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/comanche-biopharma/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    EMA Grants Orphan Drug Tag to CBP-4888 for Preeclampsia
    EMA Grants Orphan Drug Tag to CBP-4888 for Preeclampsia

    08 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/08/3057479/0/en/Comanche-Biopharma-Announces-European-Medicines-Agency-EMA-Has-Granted-Orphan-Drug-Designation-for-CBP-4888-in-sFlt1-mediated-Preterm-Preeclampsia.html

    GLOBENEWSWIRE
    08 Apr 2025
    Share Share
    Comanche’s CBP-4888 Gets UK Innovation Passport For Preeclampsia
    Comanche’s CBP-4888 Gets UK Innovation Passport For Preeclampsia

    30 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/30/3017772/0/en/Comanche-Biopharma-Awarded-Innovation-Passport-Designation-by-the-U-K-Innovative-Licensing-and-Access-Pathway-ILAP-Steering-Group-for-CBP-4888-an-Investigational-siRNA-Drug-Candida.html

    GLOBENEWSWIRE
    30 Jan 2025
    Share Share
    Comanche secures $75M to test preeclampsia siRNA in PhII
    Comanche secures $75M to test preeclampsia siRNA in PhII

    17 Jan 2024

    // ENDPTS

    https://endpts.com/comanche-secures-75m-to-test-preeclampsia-sirna-in-phii-adds-scott-gottlieb-to-board/

    ENDPTS
    17 Jan 2024
    Share Share
    Comanche Biopharma Closes Oversubscribed $75 Million Series B Financing
    Comanche Biopharma Closes Oversubscribed $75 Million Series B Financing

    17 Jan 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/01/17/2810550/0/en/Comanche-Biopharma-Closes-Oversubscribed-75-Million-Series-B-Financing-to-Advance-Mission-to-Develop-and-Make-Globally-Available-the-First-Treatment-Targeting-a-Root-Cause-of-Preec.html

    GLOBENEWSWIRE
    17 Jan 2024
    Share Share
    Comanche Biopharma Receives US FDA Fast Track Designation for CBP-4888
    Comanche Biopharma Receives US FDA Fast Track Designation for CBP-4888

    23 Aug 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/comanche-biopharma-drug-receives-fda-fast-track-designation-301908285.html

    PR NEWSWIRE
    23 Aug 2023
    Share Share
    Comanche Bio Strengthens Board of Directors with Appointment of Dr. Ann Taylor
    Comanche Bio Strengthens Board of Directors with Appointment of Dr. Ann Taylor

    13 Jun 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/comanche-biopharma-strengthens-board-of-directors-with-appointment-of-dr-ann-taylor-301849679.html

    PR NEWSWIRE
    13 Jun 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search